Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 21;321(19):1865-1866.
doi: 10.1001/jama.2019.4310.

Measuring What Matters in Diabetes

Rene Rodriguez-Gutierrez  1   2 , Rozalina G McCoy  3   4
Affiliations

Measuring What Matters in Diabetes

Rene Rodriguez-Gutierrez et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest Disclosure: RRG declares no conflicts of interest.

Comment in

  • Measuring the Quality of Diabetes Care.
    Giugliano D, Maiorino MI, Esposito K. Giugliano D, et al. JAMA. 2019 Sep 24;322(12):1212. doi: 10.1001/jama.2019.11136. JAMA. 2019. PMID: 31550021 No abstract available.

References

    1. Rodriguez-Gutierrez R, Ospina NS, McCoy RG, Lipska KJ, Shah ND, Montori VM. Inclusion of Hypoglycemia in Clinical Practice Guidelines and Performance Measures in the Care of Patients With Diabetes. JAMA Intern Med. 2016;176(11):1714. doi:10.1001/jamainternmed.2016.5046. - DOI - PMC - PubMed
    1. Spencer-Bonilla G, Quinones AR, Montori VM, International Minimally Disruptive Medicine W. Assessing the Burden of Treatment. J Gen Intern Med. 2017. - PMC - PubMed
    1. Lipska KJ, Krumholz HM. Is Hemoglobin A 1c the Right Outcome for Studies of Diabetes? JAMA. 2017;317(10):1017. doi:10.1001/jama.2017.0029. - DOI - PMC - PubMed
    1. Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: Our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504–512. doi:10.1161/CIRCOUTCOMES.116.002901. - DOI - PMC - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6. - DOI - PubMed

Publication types

MeSH terms